Stocks ZCMD Financial statements
Financial statementsZhongchao Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Zhongchao Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2017 | FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.82 | 12.9 | 14.9 | 18 | 16.3 | 14.2 | 19.4 | 15.9 | 11.4 |
| Cost of revenue | 3.97 | 4.46 | 4.66 | 6.12 | 6.86 | 7.79 | 10.9 | 6.95 | 6.25 |
| Gross profit | 5.85 | 8.41 | 10.2 | 11.9 | 9.44 | 6.36 | 8.51 | 8.91 | 5.12 |
| Research and development | 0.94 | 1.45 | 0.86 | 0.82 | 0.76 | 0.41 | 0.51 | 0.25 | 0.01 |
| Selling and marketing | 2.72 | 2.26 | 3.2 | 3.44 | 3.14 | 2.1 | 6.71 | 4.01 | 1.49 |
| General and administrative | 1.14 | 1.43 | 2.52 | 3.12 | 5.86 | 6.8 | 6.7 | 4.99 | 9.81 |
| Operating expenses | 4.8 | 5.13 | 6.58 | 7.38 | 9.76 | 9.31 | 21.8 | 9.25 | 11.3 |
| Operating income | 3.64 | 4.49 | -0.32 | -2.95 | -13.3 | -0.34 | -6.19 | ||
| Interest income | 0.19 | 0.21 | 0.25 | ||||||
| Other non-operating income | 0.28 | 0.04 | 0.53 | 0.31 | 0.03 | 0.26 | 1.07 | 0.16 | 0.08 |
| Pre-tax income | 1.34 | 3.5 | 4.39 | 4.94 | -0.11 | -2.55 | -12 | 0.06 | -5.77 |
| Income tax | -0.15 | 0.5 | 0.39 | 0.48 | -0.35 | 0.27 | -0.67 | 0.34 | 0.05 |
| Net income to minority interests | 0.03 | -0.02 | -0.05 | -0 | 0.12 | 0.03 | 0.37 | 0.5 | |
| Net income | 1.53 | 3.02 | 4.05 | 4.46 | 0.24 | -2.94 | -11.3 | -0.64 | -6.31 |
| EBITDA | 3.72 | 4.67 | 0.02 | -2.57 | -12.8 | -0.11 | -5.9 | ||
| EPS, basic | 6.00 | 11.15 | 14.37 | 14.07 | 0.77 | -9.05 | -34.83 | -0.99 | -1.85 |
| EPS, diluted | 6.00 | 11.15 | 14.37 | 14.07 | 0.77 | -9.05 | -34.83 | -0.99 | -1.85 |
| Shares, basic (weighted) | 0.25 | 0.27 | 0.28 | 0.32 | 0.31 | 0.32 | 0.33 | 0.65 | 3.42 |
| Shares, diluted (weighted) | 0.25 | 0.27 | 0.28 | 0.32 | 0.31 | 0.32 | 0.33 | 0.65 | 3.42 |
Balance sheet
| FY2017 | FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.98 | 7.92 | 7.83 | 15.1 | 13.9 | 11.5 | 7.55 | 7.84 | 8.1 |
| Short-term investments | 1.16 | 2.03 | 0.3 | 0.52 | 5.9 | 5.24 | 5.82 | ||
| Receivables | 1.99 | 5.08 | 10.3 | 9.22 | 6.77 | 2.55 | 4.68 | 2.78 | |
| Inventory | 0.19 | 0.59 | 0.59 | ||||||
| Other current assets | 0.92 | 1.26 | 1.61 | 0.38 | 0.49 | 0.45 | 0.27 | 0.23 | |
| Total current assets | 12.6 | 14.5 | 29.6 | 27.3 | 22.7 | 18.7 | 18.7 | 17 | |
| Property, plant and equipment | 0.67 | 1.89 | 2 | 3.92 | 3.89 | 3.22 | 5.87 | 5.88 | |
| Lease right-of-use assets | 0.25 | 0.07 | 0.21 | 1.67 | 0.8 | 0.09 | 0.03 | ||
| Goodwill | 5.77 | ||||||||
| Intangible assets | 0.04 | 0.04 | 0.03 | 0.03 | 0.91 | 0.02 | 0.01 | 0.01 | |
| Long-term investments | 1.26 | 1.99 | 1.18 | 1.09 | 1.23 | ||||
| Total assets | 14 | 17.7 | 34.8 | 36.3 | 38.6 | 24.4 | 25.9 | 24.1 | |
| Accounts payable | 0.02 | 0.12 | 0.41 | 0.04 | 0.14 | 0.68 | 0.54 | 0.53 | |
| Deferred revenue | 0.4 | 0.84 | 0.2 | 0.15 | |||||
| Short-term debt | 0.73 | ||||||||
| Total current liabilities | 2.33 | 2.36 | 2.98 | 3.59 | 4.17 | 2.68 | 1.53 | 1.53 | |
| Long-term debt | 2.66 | 1.84 | |||||||
| Lease liabilities | 0.04 | 0.11 | 1.22 | 0.57 | 0.02 | ||||
| Total liabilities | 2.66 | 2.4 | 2.98 | 3.7 | 5.6 | 3.38 | 1.73 | 1.55 | |
| Total debt | 2.66 | 1.84 | |||||||
| Paid-in capital | 11.9 | 12 | 22.8 | 23 | 25 | 25.1 | 29.1 | 34.5 | |
| Retained earnings | -0.38 | 3.27 | 7.34 | 7.18 | 4.12 | -7.27 | -7.96 | -14.2 | |
| Other comprehensive income | -0.17 | -0.34 | 0.92 | 1.2 | -0.51 | -1.23 | -1.71 | -1.31 | |
| Shareholders' equity | 11.4 | 15.3 | 31.8 | 32.6 | 29.9 | 18 | 20.8 | 18.6 | |
| Minority interests | -0.03 | -0.05 | 3.09 | 3.03 | 3.31 | 3.97 | |||
| Total equity | 5.2 | 11.4 | 15.3 | 31.8 | 32.6 | 33 | 21 | 24.2 | 22.6 |
| Total liabilities and equity | 14 | 17.7 | 34.8 | 36.3 | 38.6 | 24.4 | 25.9 | 24.1 |
Cash flow statement
| FY2017 | FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Net income | 1.49 | 3 | 4 | 4.46 | 0.24 | -2.82 | -11.3 | -0.27 | -5.81 |
| Depreciation and amortization | 0.01 | 0.02 | 0.08 | 0.18 | 0.34 | 0.38 | 0.52 | 0.23 | 0.29 |
| Stock-based compensation | 0.17 | 0.21 | 0.16 | 0.14 | 0.11 | 3.71 | |||
| Deferred income tax | 0.15 | -0.06 | 0.32 | 0.06 | -1.35 | 0.13 | -0.74 | 0.29 | -0.08 |
| Change in receivables | -0.78 | -0.79 | -3.13 | -5.49 | -0.1 | 1.08 | 2.79 | -2.32 | 1.17 |
| Change in inventory | -0.19 | -0.41 | -0.01 | 0.6 | |||||
| Change in payables | -0.74 | -0.55 | 0.09 | 0.26 | -0.38 | 0.1 | 0.55 | -0.13 | -0.03 |
| Cash from operations | -0.54 | 1.31 | 1.41 | -1.04 | 2.86 | -0.66 | 0.05 | -1.47 | 0.85 |
| Capital expenditures | -0.03 | -0.67 | -1.31 | ||||||
| Acquisitions | -0.16 | -0.23 | |||||||
| Purchases of investments | -1.75 | -2.92 | -2.46 | -2.04 | -1 | -6.32 | -10.7 | -9.38 | |
| Sales and maturities of investments | 0.2 | ||||||||
| Cash from investing | -1.84 | -0.5 | -0.2 | -4.09 | -4.02 | -3.35 | -3.75 | -1.81 | -0.83 |
| Stock issued | 11.9 | 1.85 | 3.84 | ||||||
| Cash from financing | 2.73 | 4.34 | -1.19 | 11.5 | 1.85 | 3.84 | |||
| Exchange rate effect | 0.2 | -0.21 | -0.1 | 0.88 | -0.24 | -0.27 | -0.26 | 0.24 | |
| Net change in cash | 0.55 | 4.94 | -0.09 | 7.24 | -1.16 | -2.39 | -3.97 | 0.29 | 0.26 |
| Free cash flow | -0.57 | 0.64 | 0.1 | ||||||
| Interest paid | 0.01 | 0.03 | |||||||
| Income taxes paid | 0.01 | 0.14 | 0.09 | 0 | 0.09 | 0.13 | 0.11 | 0.05 | 0.13 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 45.0% | Gross profit / revenue. |
| Operating margin | -54.4% | Operating income / revenue. |
| EBITDA margin | -51.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -50.7% | Pre-tax income / revenue. |
| Net margin | -55.5% | Net income / revenue. |
| Operating cash flow margin | 7.4% | Cash from operations / revenue. |
| Return on equity (ROE) | -32.0% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -25.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -41.6% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 0.1% | Research and development expense / revenue. |
| Stock-based pay / revenue | 32.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| D&A / revenue | 2.6% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -28.3% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -7.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -8.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -42.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -6.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -15.5% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -10.6% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -14.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -10.2% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -6.7% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -14.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -7.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 425.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 119.2% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 60.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 11.1x | Current assets / current liabilities. |
| Quick ratio | 10.9x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 9.12x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 6.4% | Total liabilities / total assets. |
| Working capital | $15.4M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $18.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.45x | Revenue / average total assets. |
| Fixed asset turnover | 1.94x | Revenue / average property, plant and equipment. |
| Receivables turnover | 3.05x | Revenue / average receivables. |
| Days sales outstanding | 120 days | 365 x average receivables / revenue. |
| Days payables | 31 days | 365 x average accounts payable / cost of revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$1.85 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$1.85 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $3.33 | Revenue / diluted weighted shares. |
| Operating cash flow per share | $0.25 | Cash from operations / diluted weighted shares. |
| Book value per share | $5.45 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $5.45 | Tangible book value / shares outstanding. |
| Cash per share | $4.07 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $8.2M | Share price x shares outstanding. |
| Enterprise value | -$5.8M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.72x | Market cap / revenue. |
| P/B | 0.44x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.44x | Market cap / tangible book value, when positive. |
| P/OCF | 9.66x | Market cap / cash from operations, when positive. |
| Earnings yield | -77.3% | Net income / market cap (the inverse of P/E). |
What was Zhongchao Inc.'s revenue in fiscal 2025?
Zhongchao Inc. reported revenue of $11.4M for fiscal 2025, 28.3% lower than the year before.
Was Zhongchao Inc. profitable in fiscal 2025?
No. It reported a net loss of $6.3M.